Ainos Gets Nasdaq Deficiency Letter on $2.5M Equity Rule; 45 Days to File Plan
AIMD has more than doubled off its 52-week low of $0.434 on light trading volume (0.1× avg).
Summary
Ainos received a November 18 Nasdaq notice that its $1.72M stockholders' equity falls short of the $2.5M minimum, with a compliance plan due January 4, 2027. The proposed fixes — debt conversion and new capital — point to further dilution for a company already flagged with going-concern doubt.
Key Events · Legal and Risk Events · AIMD
-
Nasdaq Minimum Equity Deficiency
A letter dated November 18, 2026 states that Ainos is not in compliance with Nasdaq Listing Rule 5550(b)(1), which requires at least $2,500,000 in stockholders' equity for continued listing on the Nasdaq Capital Market.
-
Equity Shortfall of ~$779,000
Stockholders' equity was $1,721,037 as of September 30, 2026; the company also failed the alternative market-value and net-income standards, so no alternate route to compliance is available.
-
Plan Due January 4, 2027
Ainos has 45 calendar days from the November 18 letter to submit a compliance plan; if Nasdaq accepts it, the company could receive up to 180 additional calendar days to demonstrate compliance.
-
Debt Conversion and Capital Raise Eyed
Management is evaluating converting outstanding debt into equity and other capital-raising alternatives to rebuild stockholders' equity — measures that would add shares.
Analysis · AIMD · Technology
A Nasdaq notice dated November 18, 2026 puts Ainos in breach of the Capital Market rule requiring at least $2,500,000 of stockholders' equity, and the company qualifies under neither alternative standard (market value of listed securities or net income). Equity stood at $1,721,037 as of September 30, 2026, leaving a shortfall of roughly $779,000. Trading continues for now, but the clock is running: a plan is due by January 4, 2027, and even if Nasdaq accepts it the company would get at most 180 additional days to prove compliance. Management's stated fixes are converting debt to equity and raising capital — both of which mean more shares, on top of the going-concern doubt and thin cash already disclosed in the November 16 10-Q. A second deficiency letter or a failed plan would put delisting on the table for a company already trading near $1.15.
How filings like this one have moved
In the 30 days to Nov 17, 2026, 52.4% of the 208 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -1.91%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, AIMD was trading at $1.15 on NASDAQ in the Technology sector, with a market capitalization of approximately $8.9M. The 52-week trading range was $0.43 to $3.88. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.